Focal nodular hyperplasia (FNH):: A potential cause of false-positive positron emission tomography

被引:15
|
作者
Aznar, DL
Ojeda, R
Garcia, EU
Aparici, F
Sánchez, PA
Flores, D
Martínez, C
Sopena, R
机构
[1] Hosp 12 Octubre, Dept Nucl Med, Valencia 46015, Spain
[2] Hosp 12 Octubre, Dept Radiol, Valencia 46015, Spain
[3] Hosp Dr Peset, Dept Nucl Med, Valencia, Spain
[4] Hosp La Fe, Dept Nucl Med, Valencia, Spain
关键词
focal nodular hyperplasia; FDG-PET; false-positive;
D O I
10.1097/01.rlu.0000174209.49753.a5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) has been proven to be a useful tool in the differential diagnosis of liver tumors. Focal nodular hyperplasia (FNH) is an uncommon benign liver lesion, which can be difficult to differentiate from other benign and malignant liver pathologies. FDG PET imaging usually shows uptake similar or even decreased compared to that of the normal liver. We describe a hypermetabolic FNH lesion in a patient with a history of breast cancer. Computed tomography scan, ultrasonography (US), and magnetic resonance imaging were negative. The lesion was resected, and histologic findings were consistent with FNH. Copyright © 2005 by Lippincott Williams & Wilkins.
引用
收藏
页码:636 / 637
页数:2
相关论文
共 50 条
  • [41] The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules
    Rebouissou, Sandra
    Couchy, Gabrielle
    Libbrecht, Louis
    Balabaud, Charles
    Imbeaud, Sandrine
    Auffray, Charles
    Roskams, Tania
    Bioulac-Sage, Paulette
    Zucman-Rossi, Jessica
    JOURNAL OF HEPATOLOGY, 2008, 49 (01) : 61 - 71
  • [42] INCIDENT FOCAL NODULAR HYPERPLASIA (FNH) AND ASSOCIATED RISK FACTORS IN PEDIATRIC CANCER SURVIVORS
    Wallace, Aaron
    Lewis, Rebecca Williamson
    Castellino, Sharon
    Effinger, Karen
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S206 - S207
  • [43] CYP1A1 alleles in women with focal nodular hyperplasia of the liver (FNH)
    Lazar, A
    Menzel, H
    Cascorbi, I
    Kümel, G
    Sachs, M
    Rietbrock, S
    Roots, I
    Fuhr, U
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (02) : 78 - 82
  • [44] Radiographic properties of injected calcium hydroxylapatite: potential false positive findings on positron emission tomography
    Damrose, E. J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2008, 122 (12): : 1394 - 1396
  • [45] Positron emission tomography (PET/CT) using fluoro-choline allows to differentiate adenoma from focal nodular hyperplasia
    Bumsel, F.
    Huchet, V.
    Arrive, L.
    Wendum, D.
    Paye, F.
    Poupon, R.
    Talbot, J. N.
    Rosmorduc, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S140 - S140
  • [46] Positron emission tomography (PET/CT) using fluro-choline allows to differentiate between adenoma and focal nodular hyperplasia
    Bumsel, Franck
    Huchet, Virginie
    Arrive, Lionel
    Wendum, Dominique
    Paye, Francois
    Poupon, Raoul
    Talbot, Jean-Noel
    Rosmorduc, Olivier
    HEPATOLOGY, 2007, 46 (04) : 433A - 433A
  • [47] False-positive F-18-fluorodeoxyglucose positron emission tomography/computed tomography in a patient with metallic implants following chondrosarcoma resection
    Zhou, Pu
    Tang, Jinliang
    Zhang, Dong
    Li, Guanghui
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (05) : 830 - 832
  • [48] A False-Positive Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging Result for a Patient After Augmentation Mammaplasty
    Kobe, Kyoko
    Chin, Takafumi
    Aoki, Ritsu
    Hyakusoku, Hiko
    AESTHETIC PLASTIC SURGERY, 2009, 33 (04) : 611 - 615
  • [49] A False-Positive Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging Result for a Patient After Augmentation Mammaplasty
    Kyoko Kobe
    Takafumi Chin
    Ritsu Aoki
    Hiko Hyakusoku
    Aesthetic Plastic Surgery, 2009, 33 : 611 - 615
  • [50] False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques
    Tjalma, WAA
    Carp, L
    de Beeck, BO
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 726 - 728